TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06615635: Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Sponsor: Alpha Tau Medical LTD. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 28 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$2,032,800

Rescue Site Savings

+$1,339,800

Unlock Full NCT06615635 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06615635 Rescue Dossier →